ENGN — enGene Holdings Balance Sheet
0.000.00%
- $416.49m
- $174.41m
- 41
- 28
- 66
- 41
Annual balance sheet for enGene Holdings, fiscal year end - October 31st, millions except per share.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | |
Standards: | — | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | — | 11 | 20.4 | 81.5 |
Net Total Receivables | — | 1.62 | 1.34 | 2.34 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | — | 13.5 | 22.6 | 85.4 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | — | 0.571 | 0.387 | 0.589 |
Other Long Term Assets | ||||
Total Assets | — | 15 | 23.9 | 87 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | — | 3.22 | 5.1 | 5.26 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | — | 15.4 | 47.4 | 14.5 |
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | — | -0.324 | -23.5 | 72.5 |
Total Liabilities & Shareholders' Equity | — | 15 | 23.9 | 87 |
Total Common Shares Outstanding |